检索历史清除

首页> The oncologist> A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas

A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas

导出原文传递

翻译打印收藏纠错

作者： Shepard, Gregg ^[1] ; Arrowsmith, Edward R. ; Murphy, Patrick ; Barton, John H., Jr. ; Peyton, James D. ; Mainwaring, Mark ; Blakely, Laura ; Maun, Noel A. ; Bendell, Johanna C.

作者单位： Sarah Cannon Res Inst, Nashville, TN USA ^[1]

发布时间 2018-03-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交